INVO Bioscience logo

INVO BioscienceNASDAQ: INVO

Profile

Sector:

Healthcare

Country:

United States

IPO:

02 November 2020

Next earnings report:

13 November 2024

Last dividends:

N/A

Next dividends:

N/A
$3.34 M
-92%vs. 3y high
9%vs. sector
-vs. 3y high
-vs. sector
-100%vs. 3y high
13%vs. sector
-98%vs. 3y high
15%vs. sector

Price

regular market | Mon, 28 Oct 2024 13:30:00 GMT
$0.85+$0.02(+1.96%)

Dividend

No data over the past 3 years
$1.84 M-$2.25 M

Analysts recommendations

Institutional Ownership

INVO Latest News

INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
globenewswire.com21 October 2024 Sentiment: POSITIVE

SARASOTA, Fla. and MIAMI, Oct. 21, 2024 (GLOBE NEWSWIRE) -- INVO Biosciences (Nasdaq: INVO), a company focused on expanding its portfolio of clinical and commercial-stage assets in fertility, oncology, and autoimmune diseases through the merger of INVO Biosciences and NAYA Biosciences, today confirmed it has changed its corporate name to NAYA Biosciences Inc. and will begin trading under the new symbol “NAYA” at the market open on Tuesday, October 22, 2024.

Why Is Invo Bioscience (INVO) Stock Up 85% Today?
InvestorPlace17 April 2024 Sentiment: NEUTRAL

Invo Bioscience (NASDAQ: INVO) stock is surging today after the company released its earnings report for the fourth quarter of 2023, which showed a $2 million net loss for the healthcare services fertility company.

Why Is INVO Bioscience (INVO) Stock Up 325% Today?
InvestorPlace23 October 2023 Sentiment: POSITIVE

One of the most impressive movers making the most noise in today's session has to be INVO Bioscience (NASDAQ: INVO ). Shares of INVO stock have more than tripled in today's session, surging well more than 325% at the time of writing.

INVO Bioscience, Inc. (INVO) Q2 2023 Earnings Call Transcript
Seeking Alpha14 August 2023 Sentiment: NEUTRAL

INVO Bioscience, Inc. (NASDAQ:INVO ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Robert Blum - Investor Relations Steve Shum - Chief Executive Officer Mike Campbell - Chief Operating and Vice President, Business Development Andrea Goren - Chief Financial Officer Operator Good afternoon. And welcome, to the INVO Bioscience Second Quarter Fiscal Year 2023 Financial Results Conference Call.

Why Is INVO Bioscience (INVO) Stock Up 82% Today
InvestorPlace26 June 2023 Sentiment: POSITIVE

INVO Bioscience (NASDAQ: INVO ) stock is on the rise Monday after the company announced a public share offering on Friday. According to a Securities and Exchange Commission (SEC) filing from INVO Bioscience, certain investors may offer up to 6,241,493 shares of INVO stock.

INVO Bioscience, Inc. (INVO) Q1 2023 Earnings Call Transcript
Seeking Alpha15 May 2023 Sentiment: POSITIVE

INVO Bioscience, Inc. (NASDAQ:INVO ) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Robert Blum - Lytham Partners Steve Shum - CEO Mike Campbell - Chief Operating Officer and VP of Business Development Andrea Goren - Chief Financial Officer Conference Call Participants Joanne Lee - Maxim Group Rodney Baber - Paulson Investments Operator Good day. And welcome to the INVO First Quarter 2023 Financial Results Conference Call.

INVO Bioscience, Inc. (INVO) Q4 2022 Earnings Call Transcript
Seeking Alpha17 April 2023 Sentiment: NEUTRAL

INVO Bioscience, Inc. (NASDAQ:INVO) Q4 2022 Earnings Conference Call April 17, 2023 4:30 PM ET

INVO Bioscience Announces Pricing of $3 Million Registered Direct Offering Priced At-The-Market
Pulse225 March 2023 Sentiment: NEUTRAL

INVO Bioscience announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional investor to buy 3,680,000 shares of common stock. The post INVO Bioscience Announces Pricing of $3 Million Registered Direct Offering Priced At-The-Market appeared first on Pulse 2.0.

What type of business is INVO Bioscience?

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

What sector is INVO Bioscience in?

INVO Bioscience is in the Healthcare sector

What industry is INVO Bioscience in?

INVO Bioscience is in the Medical Devices industry

What country is INVO Bioscience from?

INVO Bioscience is headquartered in United States

When did INVO Bioscience go public?

INVO Bioscience initial public offering (IPO) was on 02 November 2020

What is INVO Bioscience website?

https://www.invobioscience.com

Is INVO Bioscience in the S&P 500?

No, INVO Bioscience is not included in the S&P 500 index

Is INVO Bioscience in the NASDAQ 100?

No, INVO Bioscience is not included in the NASDAQ 100 index

Is INVO Bioscience in the Dow Jones?

No, INVO Bioscience is not included in the Dow Jones index

When was INVO Bioscience the previous earnings report?

No data

When does INVO Bioscience earnings report?

The next expected earnings date for INVO Bioscience is 13 November 2024